<DOC>
	<DOCNO>NCT01499511</DOCNO>
	<brief_summary>ASCOT-10 follow-up study survive participant United Kingdom ( UK ) arm Anglo-Scandinavian Cardiac Outcomes Trial ( ASCOT ) conduct 2000 2005.ASCOT 's result show substantial cardiovascular benefit : 1 ) use cholesterol lower drug ( atorvastatin ) compare placebo , 2 ) use blood-pressure lowering strategy base amlodipine compare strategy base atenolol . ASCOT-10 test hypothesis ASCOT subject originally receive Atorvastatin receive amlodipine base treatment continue show cardiovascular benefit relative , even though subject access optimal treatment interim .</brief_summary>
	<brief_title>Anglo-Scandinavian Cardiac Outcomes Trial : Post Trial Follow-Up Study</brief_title>
	<detailed_description>Study investigator access information ASCOT patient study centre die since end ASCOT study 2005 . Of 8580 ASCOT patient United Kingdom , 7300 flag The Information Centre Health Social Care end trial 2005.This flagging process re-activated 2010 death incident cancer relate patient send every three month ASCOT-10 co-ordinating centre . These result identify ASCOT study number , personal data remove . These deceased patient number communicate participate site trial centre staff contact family . An attempt make contact remain patient participate UK ASCOT sit . Initial contact make via general practitioner ( GP ) surgery . If GP provide up-to-date contact detail feel appropriate contact patient , patient send introductory letter , patient information sheet , consent form health questionnaire . They ask complete 'tick-box ' form give follow option : 1 . Willing complete health questionnaire . 2 . Willing information health give GP next kin . 3 . Willing give information telephone . 4 . Willing attend study clinic single visit . 5 . Not willing take part . They ask complete form , sign , date return pre-paid envelope trial centre . This form use consent form questionnaire part study . They also ask complete simple health questionnaire . This collect information health problem experience since end ASCOT trial ( particular heart attack strokes/mini-strokes ) , well information hospital admission period current medication . In addition , information current weight , exercise , alcohol consumption , smoke general quality life collect . Patients ask return complete questionnaire , along consent/reply form , local trial centre . If study team receive response within four week , reminder letter sent . If response obtain four week , final attempt make contact patient letter telephone call . 10 % study population trial centre , choose random , invite attend trial centre single clinic visit . Further inform consent follow discussion member ( ) study team obtain . During clinic visit questionnaire review several measurement take follow : - Blood pressure - Weight - Pulse wave analysis . ( This simple , non-invasive test , much like blood pressure measurement , give u information function heart artery ) - Blood creatinine estimate glomerular filtration rate ( eGFR ) ( test kidney function ) , electrolytes ( sodium potassium ) , fast lipid ( cholesterol ) , fast glucose , glycated haemoglobin ( test diabetes ) An additional blood test take plasma store later analysis chemical blood might predict cardiovascular risk . Precise detail test currently available . However , plasma store securely identifiable data present sample ( i.e . store anonymously , identify subject 's study number ) . Every effort take contact patient move since ASCOT study close contact detail available . This may do health service track service , available , via Primary Care Trusts ( PCTs ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Surviving ASCOT participant participate UK site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Mortality</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Stroke</keyword>
	<keyword>Diabetes</keyword>
</DOC>